A novel natural product (1), with antifungal activity was isolated from the culture broth of an actinomadurae. The active compound was separated from broth by n-butanol extraction and purified by silica gel and multicoil counter current chromatography. Physico-chemical data suggested the structure of this compound to be a novel macrolactam disaccharide related to Sch 38518 (3). The structure was determined by spectroscopic studies on the acetate derivative. It was active against Candida spp. (MIC's, 4 approximately 64 micrograms/ml) but less than the monosaccharide, Sch 38518 (MIC's, 1 approximately 16 micrograms/ml).

Download full-text PDF

Source
http://dx.doi.org/10.7164/antibiotics.46.1109DOI Listing

Publication Analysis

Top Keywords

sch 38518
8
mic's micrograms/ml
8
novel macrolactam-disaccharide
4
macrolactam-disaccharide antifungal
4
antifungal antibiotic
4
antibiotic taxonomy
4
taxonomy fermentation
4
fermentation isolation
4
isolation physico-chemical
4
physico-chemical properties
4

Similar Publications

Article Synopsis
  • Fluvirucins are 14-membered macrolactam compounds with antifungal and antiviral properties, derived from a β-alanine starter unit in their chemical structure.
  • Researchers have identified a specific biosynthetic gene cluster in Actinomadura fulva, which is responsible for producing fluvirucin B2 and includes several key enzymes.
  • The study highlights the adenylation enzyme FlvN's role in the biosynthesis of fluvirucin B2, showing its strong preference for l-aspartate over other amino acids, leading to a proposed pathway for fluvirucin production.
View Article and Find Full Text PDF

Efficient approach to fluvirucins B2-B5, Sch 38518, and Sch 39185. First synthesis of their aglycon, via CM and RCM reactions.

Org Lett

August 2009

Departament de Química Orgànica, Facultat de Química, Universitat de Barcelona, Av. Diagonal 647, 08028 Barcelona, Catalonia, Spain.

A route to fluvirucinins B(2-5) (the common aglycon of fluvirucins B(2)-B(5), Sch 38518, and Sch 39185) is reported for the first time. A ring-closing metathesis (RCM) generated the C6-C7 double bond, which by catalytic hydrogenation (in toluene) gave the desired epimer with a 9:1 diastereoselection. Azide 8a and carboxylic acid 5 came from ethyl-branched fragments C9-C13 (CHO at C9) and C1-C5 via an asymmetric allylation of the former and a cross metathesis (CM) followed by a ketone methylenation (with 20 mol % of DMF as a sacrificial additive) of the latter.

View Article and Find Full Text PDF

A novel secondary metabolite SCH 42282 (1), with antifungal activity was isolated from the fermentation broth of a soil actinomycete identified as a Microtetraspora sp. The active compound was separated from the fermentation broth by butanol extraction and purified on a silica gel column and by multi-coil counter current chromatography. The compound was identified as a novel macrolactam trisaccharide related to SCH 38518 (4).

View Article and Find Full Text PDF

A novel natural product (1), with antifungal activity was isolated from the culture broth of an actinomadurae. The active compound was separated from broth by n-butanol extraction and purified by silica gel and multicoil counter current chromatography. Physico-chemical data suggested the structure of this compound to be a novel macrolactam disaccharide related to Sch 38518 (3).

View Article and Find Full Text PDF

Macrolactams: a novel class of antifungal antibiotics produced by Actinomadura spp. SCC 1776 and SCC 1777.

J Antibiot (Tokyo)

May 1992

Microbial Products, Schering-Plough Research, Bloomfield, NJ 07003.

Three novel antifungal antibiotics, Sch 38518, Sch 39185 and Sch 38516 were isolated from the fermentation broths of two actinomycetes identified by chemical, morphological and physiological analysis as a new species of Actinomadura. The compounds were isolated from broth by solvent extraction and purified by silica gel chromatography. Physico-chemical properties, mass spectral analysis, IR and UV suggested the compounds were similar.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!